268 related articles for article (PubMed ID: 6440553)
1. Platelet prostanoids in interaction of platelets with collagen substrates. II. Effects of exogenous arachidonic acid, stable PG endoperoxides analogue, and aspirin.
Mazurov AV; Leytin VL; Repin VS; Taube C; Förster W
Biomed Biochim Acta; 1984; 43(8-9):S373-6. PubMed ID: 6440553
[TBL] [Abstract][Full Text] [Related]
2. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
Mazurov AB; Leĭtin VL; Repin VS
Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
[TBL] [Abstract][Full Text] [Related]
3. Arachidonic acid and stable analogue of prostaglandin endoperoxides (U46619) induce platelet spreading and thrombi-like aggregate formation on a collagen substrate. Effect of fluid dynamics.
Mazurov AV; Leytin VL; Repin VS; Smirnov VN; Förster W
Thromb Res; 1983 Oct; 32(2):189-205. PubMed ID: 6419375
[TBL] [Abstract][Full Text] [Related]
4. Antianginal drug trapidil (Rocornal) inhibits spreading of platelets and formation of surface-bound thrombi-like aggregates.
Mazurov AV; Leytin VL; Repin VS; Smirnov VN; Taube C; Förster V
Thromb Res; 1983 Nov; 32(3):255-66. PubMed ID: 6419377
[TBL] [Abstract][Full Text] [Related]
5. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of thrombocyte spreading and the formation of thrombus-like aggregates bound with substrate by the anti-anginal agent trapidil].
Mazurov AV; Leĭtin VL; Repin VS
Vopr Med Khim; 1984; 30(4):110-6. PubMed ID: 6438908
[TBL] [Abstract][Full Text] [Related]
7. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
8. Platelet prostanoids in interaction of platelets with collagen substrates. I. Activation of platelets by surfaces coated with different types of human collagen.
Leytin VL; Misselwitz F; Domogatsky SP; Jahn S; Hofmann U; Repin VS
Biomed Biochim Acta; 1984; 43(8-9):S331-4. PubMed ID: 6517901
[TBL] [Abstract][Full Text] [Related]
9. [Stimulation of spreading and aggregation of platelets on immobilized type V collagen: mechanisms depending on Ca2+ and protein kinase C].
Leĭtin VL; Missel'vitts F; Avdonin PV; Liubimova EV; Domogatskiĭ SP
Biokhimiia; 1989 Sep; 54(9):1565-70. PubMed ID: 2590687
[TBL] [Abstract][Full Text] [Related]
10. Influence of thromboxane receptor-antagonists on the interaction of platelets with solid-phase immobilized human collagen.
Misselwitz F; Hofmann U; Leytin VL; Repin VS
Biomed Biochim Acta; 1987; 46(7):595-8. PubMed ID: 2962573
[TBL] [Abstract][Full Text] [Related]
11. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G
Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235
[TBL] [Abstract][Full Text] [Related]
13. Interference of the thromboxane antagonist SK&F 88046 with platelet activation and subsequent desensitization by arachidonic acid and the thromboxane mimetics U46619 and EP171.
Vargaftig B; Joseph D; Hatmi M
Thromb Res; 1987 May; 46(4):509-17. PubMed ID: 3039684
[TBL] [Abstract][Full Text] [Related]
14. Platelets, eicosanoids, and coronary vasospasm.
Schrör K; Verheggen R
Prog Clin Biol Res; 1987; 242():165-70. PubMed ID: 3118379
[No Abstract] [Full Text] [Related]
15. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
Carmo LG; Hatmi M; Rotilio D; Vargaftig BB
Br J Pharmacol; 1985 Aug; 85(4):849-59. PubMed ID: 2994786
[TBL] [Abstract][Full Text] [Related]
16. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
Glass F; Lippton H; Kadowitz PJ
Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
[TBL] [Abstract][Full Text] [Related]
17. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
Block HU; Förster W; Heinroth I
Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation induced by a stable analogue of endoperoxides (U46619).
Zatta A; Prosdocimi M
Thromb Haemost; 1989 Apr; 61(2):328-9. PubMed ID: 2526389
[No Abstract] [Full Text] [Related]
19. Phorbol ester stimulates platelet spreading and thrombi-like aggregate formation on the surface of immobilized type V collagen.
Leytin VL; Misselwitz F; Avdonin PV; Podrez FA; Domogatsky SP; Tkachuk VA
Thromb Res; 1989 Aug; 55(3):309-18. PubMed ID: 2781531
[TBL] [Abstract][Full Text] [Related]
20. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
Patscheke H; Stegmeier K
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
